• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[再狭窄的局部治疗概念]

[Concepts for local therapy of restenosis].

作者信息

Riessen R, Oberhoff M, Karsch K R

机构信息

Med. Klinik III, Universität Tübingen.

出版信息

Z Kardiol. 1996;85 Suppl 1:87-98.

PMID:8882829
Abstract

Local drug delivery is a new therapeutic approach targeted at the prevention of restenosis after coronary balloon angioplasty. Several mostly catheter-based devices have been designed to deliver medications with, for example, antithrombotic or antiproliferative actions directly at the site of angioplasty. Besides delivery of conventional pharmacologic agents, novel therapeutic strategies based on molecular mechanisms (e.g., gene transfer or antisense oligonucleotides) are currently under investigation and at the threshold of clinical trials. In addition, local radiation with either radioactive wires or stents has shown promising results in first experimental studies. More investigations are necessary, however, to clearly demonstrate the efficacy of the various local delivery approaches, with a special emphasis on safety aspects.

摘要

局部药物递送是一种旨在预防冠状动脉球囊血管成形术后再狭窄的新型治疗方法。已经设计了几种主要基于导管的装置,用于在血管成形术部位直接递送具有抗血栓或抗增殖作用等的药物。除了递送传统的药理剂外,基于分子机制的新型治疗策略(例如基因转移或反义寡核苷酸)目前正在研究中,并且即将进入临床试验阶段。此外,使用放射性导线或支架进行局部放射在最初的实验研究中已显示出有希望的结果。然而,需要更多的研究来清楚地证明各种局部递送方法的疗效,尤其要强调安全性方面。

相似文献

1
[Concepts for local therapy of restenosis].[再狭窄的局部治疗概念]
Z Kardiol. 1996;85 Suppl 1:87-98.
2
[Drug and instrumental therapeutic approaches for prevention of restenosis].[预防再狭窄的药物及器械治疗方法]
Z Kardiol. 1995;84 Suppl 4:151-8.
3
[Local drug administration systems, preclinical and clinical use: perspectives and limitations].[局部给药系统,临床前和临床应用:前景与局限]
Z Kardiol. 1996 Mar;85(3):155-65.
4
Drug-eluting stent: the emerging technique for the prevention of restenosis.药物洗脱支架:预防再狭窄的新兴技术。
Minerva Cardioangiol. 2002 Oct;50(5):443-53.
5
[New strategies in the treatment of restenosis].
Z Kardiol. 2000;89 Suppl 7:19-22.
6
[State of treatment of coronary artery disease by drug releasing stents].[药物洗脱支架治疗冠状动脉疾病的现状]
Herz. 2002 Sep;27(6):508-13. doi: 10.1007/s00059-002-2426-z.
7
Current status of biodegradable stents.可生物降解支架的现状
Cardiol Clin. 1994 Nov;12(4):699-713.
8
[New understanding in the prevention of post-coronary angioplasty restenosis].[冠状动脉成形术后再狭窄预防的新认识]
Harefuah. 2000 Dec;139(11-12):457-62.
9
[Standards in interventional therapy of coronary artery disease].[冠状动脉疾病介入治疗的标准]
Herz. 2002 Sep;27(6):481-501. doi: 10.1007/s00059-002-2385-4.
10
Restenosis related to percutaneous coronary intervention has been solved?经皮冠状动脉介入治疗相关的再狭窄问题解决了吗?
Ann Med. 2006;38(3):173-87. doi: 10.1080/07853890600643404.